CD274 and non-small cell lung carcinoma: We showed that a novel automated image analysis scoring algorithm can be used to determine tumor cell PD-L1 positivity in patients with non-small cell lung cancer and that it demonstrates high analytical concordance with pathologist ratings, permitting quantitative comparison of existing immunohistochemistry assays in order to confirm previous findings [25].